09 September 2002
Heparin reduces oxidative stress in the postoperative period
Łukasz Dzieciuchowicz, Paweł Chęciński, Hanna KraussMed Sci Monit 2002; 8(9): CR657-660 :: ID: 13491
Abstract
Background: The purpose of our study was to investigate the influence of low-dose heparin on peroxide levels and the antioxidant activity of superoxide dysmutase (SOD), catalase (CAT), and glutathione
peroxidase in the red blood cells of patients undergoing minor abdominal surgery.
Material/Methods: 49 patients scheduled for open cholecystectomy, with a median age of 43, were randomly assigned to either the heparin group (HG) or the placebo group (PG). HG patients received a
subcutaneous dose of 100 IU/kg body weight of standard heparin for 6 days, beginning the first day after surgery. On the day prior to surgery and on the 1st, 2nd and 6th postoperative days, blood samples from peripheral veins were collected, and the levels of peroxides, superoxide dysmutase (SOD), catalase (CAT) and glutathione peroxidase activity in the hemolysate of red blood cells were determined. The level of malondialdehyde was also measured.
Results: Significantly lower levels of peroxides, as well as higher antioxidant activity of SOD and CAT, was found in the erythrocytes of HG patients. Heparin administration did not significantly influence the activity of glutathione peroxidase. There were also no differences in the levels of malondialdehyde between HG and PG patients.
Conclusions: Low-dose standard heparin administered subcutaneously in patients undergoing minor abdominal surgery shows an antioxidant effect. Further studies are required to clarify the mechanism of increased SOD and CAT activity in red blood cells induced by heparin.
Keywords: Anticoagulants - pharmacology, Catalase - blood, Catalase - metabolism, Cholecystectomy, Erythrocytes - enzymology, Glutathione Peroxidase - blood, Heparin - pharmacology, Malondialdehyde - metabolism, Oxidative Stress - drug effects, Peroxides - blood, Postcholecystectomy Syndrome - blood, Superoxide Dismutase - blood, Time Factors
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...Med Sci Monit In Press; DOI: 10.12659/MSM.943797
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952